Arm’s Nasdaq Debut Surges, Valuation Tops $64bn

September 14, 2023
Arm's Nasdaq Debut Surges, Valuation Tops $65bn

In a remarkable Nasdaq debut on Thursday, chip designer Arm saw its shares soar, closing at $63.59 per share, a significant increase from the $51 offer price just the evening before.

This surge in stock price not only valued the SoftBank-backed company at over $65 billion but also marked the largest U.S. listing in nearly two years, raising almost $5 billion for SoftBank.

Join our WhatsApp Channel

Rene Haas, Arm’s CEO, seized the opportunity to highlight the company’s transformation since SoftBank’s acquisition in 2016, emphasizing its diversification beyond the mobile market into automotive and data center chips. Haas stated, “We are far more diversified.”

Despite SoftBank selling about 10% of Arm in the IPO, Haas revealed that SoftBank had been a net buyer of Arm’s shares, emphasizing their optimism about the company’s future. “The best days for our company are ahead of us,” Haas added.

This strong reception for Arm’s listing is expected to boost confidence in the broader IPO market, which has been gradually recovering from a challenging fundraising environment.

While Arm’s stock experienced a significant first-day surge, it reflected SoftBank’s strategic focus on ensuring the stock trades well rather than maximizing initial payouts. SoftBank’s long-term interest in protecting the value of its 90% ownership of Arm played a pivotal role in the pricing decisions.

Barclays, Goldman Sachs, JP Morgan, and Mizuho served as lead bookrunners on the IPO, with 24 additional banks participating as underwriters.

Arm’s successful debut sets a positive tone for the IPO market, with upcoming listings like Instacart and Klaviyo expected to further test investor appetite. However, it’s worth noting that while a strong initial “pop” can be exciting, it can also indicate that companies could have raised more capital in the initial offering.

emmmmmm
+ posts

Emmanuel Ochayi is a journalist. He is a graduate of the University of Lagos, School of first choice and the nations pride. Emmanuel is keen on exploring writing angles in different areas, including Business, climate change, politics, Education, and others.

Emmanuel Ochayi

Emmanuel Ochayi is a journalist. He is a graduate of the University of Lagos, School of first choice and the nations pride. Emmanuel is keen on exploring writing angles in different areas, including Business, climate change, politics, Education, and others.

Previous Story

Nigeria National Rugby Coach Unveils 12-man Team For Africa Cup Rugby Tournament

US Reveals Ways China Could Influence Nigerian Gov’t's Decisions
Next Story

Joe Biden Faces Intense Pressure Over Son’s New Gun Charges 

Featured Stories

Latest from Business News

Gambia Orders Banks to Replace Non-Gambian Staff by Year-End

Written by Amanze Chinonye The Central Bank of The Gambia has directed commercial banks to phase out non-Gambian employees and replace them with suitably qualified Gambian nationals by Dec. 31, as the regulator tightens enforcement of rules governing expatriate employment in the banking

Dangote, Ethiopia and Djibouti Unveil $660m Fuel Pipeline Plan

Written by Amanze Chinonye Ethiopia, Djibouti and Nigerian industrialist Aliko Dangote plan to invest $660 million in a refined petroleum products pipeline connecting the two East African countries, seeking to lower fuel transportation costs and strengthen energy security. Join our WhatsApp Channel The

Lithium: Will Nigeria Repeat the Oil Curse?

Written by MARCEL MBAMALU There is a road out of Lafia where trucks leave every night loaded with stones that will power Tesla batteries in Berlin and solar storage in Beijing, but cannot power the village they left. That is the story of
Previous Story

Nigeria National Rugby Coach Unveils 12-man Team For Africa Cup Rugby Tournament

US Reveals Ways China Could Influence Nigerian Gov’t's Decisions
Next Story

Joe Biden Faces Intense Pressure Over Son’s New Gun Charges 

Don't Miss

Why NAFDAC Banned Multi-dose Anti-malarial Drug

Five Best Performing Pharmaceutical Companies In H1 2026 — By Revenue Growth

The pharmaceutical industry generated over N142.54 billion in revenue between

BBNaija 10: Otega, Kayikunmi Evicted From Show

The Big Brother Naija Season 10 show, themed 10/10, witnessed